Skip to content

Avanos Medical AVNS Gross margin

Gross margin at other companies

Stryker logo
StrykerSYK
63.8%-0.1pp
Cardinal Health logo
Cardinal HealthCAH
3.8%+0.2pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
79.3%+1.7pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
60.7%+3.0pp

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Calculated from Avanos Medical’s reported figures.

Based on trailing twelve months.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's gross margin?
Avanos Medical (AVNS) reported gross margin of 50% in Q1 2026.
How has Avanos Medical's gross margin changed year-over-year?
Avanos Medical's gross margin decreased by 8.3% year-over-year, from 54.6% to 50%.
What is the long-term trend for Avanos Medical's gross margin?
Over 5 years (2020 to 2025), Avanos Medical's gross margin has grown at a -0.6% compound annual growth rate (CAGR), from 51.9% to 50.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.